NCT05460234Completed
RAYALDEE Non Interventional Study (NIS) on Effectiveness in ND-CKD SHPT Patients
Non-interventional Study to Collect Real-world Effectiveness, Safety, and Adherence Data on Extended-release Calcifediol (Rayaldee®) in Non-dialysis CKD Patients With Secondary Hyperparathyroidism. Protocol Version 2.0, 06DEC2023
Source: ClinicalTrials.gov · Last updated 15 Jul 2025
Brief summary (registry, in English)
The overall study objective is to collect real-world data on the safety and effectiveness of ERC to gradually increase 25D to the level required by Stage 3 and 4 CKD patients. ERC (Rayaldee), a prolonged-release calcifediol (PRC) formulation, is an orally administered prohormone of active Vitamin D (1,25-dihydroxyvitamin D (1,25D)) designed to increase serum total 25D safely and to a high enough magnitude to reliably reduce elevated PTH in patients with non-dialysis chronic kidney disease (ND-CKD). Clinical studies show that ERC is an effective, well tolerated treatment for secondary hyperparathyroidism (SHPT) in ND-CKD patients with Vitamin D insufficiency or deficiency. ERC gradually raises serum 25D levels, resulting in physiologically regulated increases in serum 1,25D and sustained and progressive reductions in PTH levels, while avoiding clinically meaningful increases in serum phosphate and calcium. To date, experience with the use of ERC results exclusively from patients from the US and mainly from patients who have participated in clinical trials. It is therefore of major interest to observe the value of ERC in daily use outside of the controlled trial settings in the US as well as in Europe. (Protocol v.2.0,06Dec2023).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 110 (actual)
- First submitted
- 8 Jun 2022
- Start date
- 5 Oct 2022
- Primary completion date
- 31 Jan 2024
- Lead sponsor
- Vifor (International) Inc.
- Diseases
- Chronic kidney disease
- NCT number
- NCT05460234
What you commit to
- Study type: Observational
- Participants enrolled: 110
- From 5 Oct 2022 to the primary completion date, 31 Jan 2024
- 16 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Enrolment in a prior clinical trial with ERC
Other
- Parallel participation in an interventional study
Who the study is looking for
- Signed informed consent
- Age ≥18 years
- Indication for ERC treatment in accordance with the currently approved SmPC.
- Starting ERC treatment or being on ERC treatment for a maximum of 6 months before inclusion in the study.
- Stable kidney function in the medical judgment of the investigator
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (16)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dialysepraxis Spandau - 01012 Coordinator of this site? Confirm its status | Berlin | Germany | Unknown status |
| Tagesklinik - Lehrpraxis der Charité Dialyse - Apherese -01007 Coordinator of this site? Confirm its status | Berlin | Germany | Unknown status |
| Städtisches Klinikum Braunschweig gGmbH -01006 Coordinator of this site? Confirm its status | Braunschweig | Germany | Unknown status |
| Nierenzentrum Eichstätt MVZ GmbH - 01072 Coordinator of this site? Confirm its status | Eichstätt | Germany | Unknown status |
| Universitätsklinik Greifswald Klinik und Poliklinik für Innere Medizin A -01066 Coordinator of this site? Confirm its status | Greifswald | Germany | Unknown status |
| Marien Hospital Herne-Uniklinikum - 01003 Coordinator of this site? Confirm its status | Herne | Germany | Unknown status |
| MVZ Saarpfalz GmbH - 01008 Coordinator of this site? Confirm its status | Homburg | Germany | Unknown status |
| Westpfalz-Klinikum GmbH - 01025 Coordinator of this site? Confirm its status | Kaiserslautern | Germany | Unknown status |
| Nephrologische Gemeinschaftspraxis Baumhackl & Rasche - 01028 Coordinator of this site? Confirm its status | Kulmbach | Germany | Unknown status |
| Klinikum Landshut -01002 Coordinator of this site? Confirm its status | Landshut | Germany | Unknown status |
| Universitätsklinikum Mainz - 01004 Coordinator of this site? Confirm its status | Mainz | Germany | Unknown status |
| Universitätsklinikum Münster, Medizinische Klinik D - 01073 Coordinator of this site? Confirm its status | Münster | Germany | Unknown status |
| Uniklinik Münster, Nephrologische Ambulanz - 01018 Coordinator of this site? Confirm its status | Münster | Germany | Unknown status |
| Nephrologisches Zentrum Rendsburg-Eckernförde - 01056 Coordinator of this site? Confirm its status | Rendsburg | Germany | Unknown status |
| Robert-Bosch-Krankenhaus - 01001 Coordinator of this site? Confirm its status | Stuttgart | Germany | Unknown status |
| Gim - 01013 Coordinator of this site? Confirm its status | Witten | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.